Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

197.53 +4.50 (+2.33%)
Streaming Delayed Price Updated: 11:31 AM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
From Natera, Inc.
Via Business Wire
News headline image
Small- To Mid-Cap Biotech Trades Poised For Gains ↗
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
From Natera, Inc.
Via Business Wire
News headline image
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). ↗
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA). 
Via Chartmill
News headline image
Looking Into Natera's Recent Short Interest ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Natera In The Eyes Of 14 Experts ↗
 
Via Benzinga
News headline image
Why NASDAQ:NTRA qualifies as a high growth stock. ↗
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing? 
Via Chartmill
News headline image
Natera to Present New Data at the 2025 ASCO GI Symposium
From Natera, Inc.
Via Business Wire
News headline image
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone ↗
The company is working to expand the uses and reimbursement for its blood-based tests for cancer. 
Via Investor's Business Daily
News headline image
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio? ↗
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,... 
Via Benzinga
News headline image
The End Of The 60/40 Portfolio ↗
Since bonds don't protect against stock declines, it's time for a different approach. 
Via Benzinga
Topics Bonds
News headline image
Exploring NASDAQ:NTRA's high growth characteristics. ↗
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). 
Via Chartmill
News headline image
Looking Into Natera's Recent Short Interest ↗
 
Via Benzinga
News headline image
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
From Natera, Inc.
Via Business Wire
News headline image
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings ↗
Via The Motley Fool
News headline image
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Natera, Inc.
Via Business Wire
News headline image
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next ↗
Druckenmiller's Duquesne Family Office sold Nvidia and Palantir stocks while increasing stake in Teva Pharmaceutical, signaling a shift in investment focus. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings ↗
Via The Motley Fool
News headline image
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252% ↗
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million. 
Via Benzinga
News headline image
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
From Natera, Inc.
Via Business Wire
News headline image
Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
From Natera, Inc.
Via Business Wire
News headline image
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
From Natera, Inc.
Via Business Wire
News headline image
Natera Issues Statement on Guardant Health Litigation
From Natera, Inc.
Via Business Wire
News headline image
Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
From Natera, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.